DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SOYA LECITHIN SOLID DISPERSION: IN VITRO AND PHARMACODYNAMIC INVESTIGATION

  • SURESH GAUTAM Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002
  • YOGESH NIKALAJE Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002
  • DARSHANA BHADRE Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002
  • RASHMI TRIVEDI Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002
  • MILIND UMEKAR Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002
  • JAYSHREE TAKSANDE Department of Pharmaceutics, Shrimati Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (M. S.), India 441002

Abstract

Objective: Epilepsy is a common neurodegenerative disorder characterized by spontaneous and repeated attacks of convulsions. It requires immediate pharmacotherapy to prevent its progression to status epilepticus. However, most of the anticonvulsant drugs are poorly water-soluble and demonstrate the delayed onset of action. Thus there is a need to improve its solubility for the better pharmaceutical profile. The objective of the present investigation was to enhance the solubility of lamotrigine incorporating soya lecithin as a phospholipid carrier by solid dispersion technique


Methods: Solid dispersions of lamotrigine were prepared with soya lecithin by the solvent method. The effect of concentration of phospholipid and solvents on aqueous solubility and dissolution profile of lamotrigine was analyzed.


Results: Ethanol increased lamotrigine solubility with soya lecithin in ratio 5:1. X-ray diffraction and scanning electron micrograph indicated a smaller crystallite size of lamotrigine with fairly uniform size distribution in the lamotrigine-soya lecithin solid dispersion. The resultant solid dispersion also significantly delayed the onset of clonic convulsion (875.8 s) as compared to control (85.5 s) and offered complete protection (100%) against the pentylenetetrazole induced seizures in the rat as compared to control (33.33%). Also, solid dispersion with maximum drug content (77.68%) and dissolution rate (91.40%) was formulated as an orodispersible tablet and characterized for its pharmaceutical properties.


Conclusion: It can be concluded that the solid dispersion of lamotrigine incorporated with soya lecithin demonstrated enhanced solubility and dissolution rate may have potential clinical application.

Keywords: Lamotrigine, Phospholipids, Solid dispersion, Anticonvulsant activity, Pentylenetetrazole

References

1. Tan L, Yu JT, Guan HS. Intranasal anticonvulsive treatment: prospective management of intractable epilepsy? Med Hypotheses 2008;71:542-5.
2. Lamotrigine RX. LIST, drugs a-z list lamictal (lamotrigine) drug center. Lamictal (Lamotrigine drug information, drugs a-z list, lamictal (lamotrigine) drug center; 2019.
3. Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm; 2012. p. 1-10.
4. Vimalson DC, Parimalakrishnan S, Jeganathan NS, Anbazhagan S. Solid dispersion technique to enhance the solubility and dissolution of febuxostatan BCS class II drug. Int J Appl Pharm 2019;11:241-6.
5. Sanjaymitra PSS, Ganesh GNK. Dissolution and solubility enhancement strategies: current and novel prospectives. J Crit Rev 2018;5:1-10.
6. Goa KL, Ross SR, Chrisp P. Lamotrigine-a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152–76.
7. Hassib ST, Hashem HMA, Mahrouse MA, Mostafa EA. A validated reversed-phase high-performance liquid chromatography method for the simultaneous determination of five antiepileptic drugs used in the treatment of lennox-gastaut syndrome in their pharmaceutical dosage form. Asian J Pharm Clin Res 2018;11:167-73.
8. Mohan A, Rana R. Lamotrigine solid dispersions for solubility enhancement. Asian J Pharm 2016;10:172-7.
9. Kadam PA, Dherai AJ, Naik P, Lokhande R, Udani V, Gursahani R, et al. Retrospective study on therapeutic drug monitoring of lamotrigine in Indian epileptic patients. Int J Pharm Pharm Sci 2014;6:430-3.
10. Han HK, Choi HK. Improved absorption of meloxicam via salt formation with ethanolamines. Eur J Pharm Biopharm 2007;65:99–103.
11. Taksande JB, Lade SN, Trivedi RV, Mahore JG, Umekar MJ. Effect of hydrophilic polymer on solubility and dissolution of atorvastatin inclusion complex. Int J Pharm Chem Sci 2012;1:374-85.
12. Trivedi RV, Admane PS, Taksande JB, Mahore JG, Umekar MJ. Solubility enhancement studies of hydrochlorothiazide by preparing solid dispersions using losartan potassium and urea by different methods. Der Pharm Lett 2011;3:8-17.
13. Venkat BY, Adhikrao VY. Enhancement of solubility and dissolution rate of BCS class II pharmaceuticals by non aqueous granulation technique. Int J Pharm Res Dev 2010;1:1–11.
14. Shende AJ, Patil RR, Devarajan PV. Microemulsion of lamotrigine for nasal delivery. Indian J Pharm Sci 2007;69:721–2.
15. Patil AN, Shinkar DM, Saudagar RB. Review article: solubility enhancement by solid dispersion. Int J Curr Pharm Res 2017;9:15-8.
16. Ford JL. The current status of solid dispersions. Pharm Acta Helv 1986;61:69-88.
17. Mohan A, Gundamaraju R. In vitro and in vivo evaluation of fast-dissolving tablets containing solid dispersion of lamotrigine. Int J Pharm Invest 2015;5:57–64.
18. Mirza S, Miroshnyk I, Habib M, Brausch J, Hussain MD. Enhanced dissolution and oral bioavailability of piroxicam formulations: modulating the effect of phospholipids. Pharmaceutics 2010;2:339–50.
19. Sosada M, Gorecki M, Pasker B. Influence of rapeseed phospholipids on ibuprofen dissolution from solid dispersions. Pharmazie 2006;61:677–80.
20. Vudathala GK, Rogers JA. Dissolution of fludrocortisone from phospholipid coprecipitates. J Pharm Sci 1992;81:282–6.
21. Serajuddin ATM. Solid dispersion of poorly water-soluble drugs, early promises, subsequent problems and recent breakthroughs. J Pharm Sci 1999;88:1058-66.
22. Li J, Wang XL, Zhang T, Wang CL, Huang ZJ, Luo X, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 2015;10:81-98.
23. Van Hoogevest P, Wendel A. The use of natural and synthetic phospholipids as pharmaceutical excipients. Eur J Lipid Sci Technol 2014;116:1088–107.
24. Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–302.
25. Hussain D, Brausch F, Talukder M. Ibuprofen–phospholipid solid dispersions: Improved dissolution and gastric tolerance. Int J Pharm 2012;422:290-4.
26. Shinde VR, Shelake MR, Shetty SS, Chavan–Patil AB, Pore YV, Late SG. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. J Pharm Pharmacol 2008;60:1121-9.
27. Mali A, Nalavade S, Bathe R. Physicochemical characterization and solubility enhancement studies of felodipine solid dispersion. Int J Biomed Adv Res 2015;6:391-9.
28. Taksande JB, Wadher KJ, Trivedi RV, Umekar MJ. Development and evaluation of lamotrigine loaded N-trimethyl chitosan microspheres for intranasal administration. Int J Chem Tech Res 2017;10:1-13.
29. Taksande JB, Sonwane PP, Trivedi RV, Wadher KJ, Umekar MJ. Formulation and pharmacodynamic investigations of lamotrigine microspheres in pentylenetetrazole-induced seizures in mice. Asian J Pharm 2017;11:215-24.
Statistics
98 Views | 53 Downloads
Citatons
How to Cite
GAUTAM, S., NIKALAJE, Y., BHADRE, D., TRIVEDI, R., UMEKAR, M., & TAKSANDE, J. (2019). DEVELOPMENT AND EVALUATION OF LAMOTRIGINE SOYA LECITHIN SOLID DISPERSION: IN VITRO AND PHARMACODYNAMIC INVESTIGATION. International Journal of Applied Pharmaceutics, 12(1), 115-122. https://doi.org/10.22159/ijap.2020v12i1.35647
Section
Original Article(s)